The 2 analysts offering 1 year price forecasts for J90 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 1 analyst giving stock ratings to J90 in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
J90 EPS for the last quarter is −0.02 EUR despite the estimation of −0.03 EUR. In the next quarter EPS is expected to reach −0.02 EUR. Track more of NUREXONE BIOLOGIC INC financials and stay on top of what is up with the company.
According to analysts, J90 price target is 1.90 EUR with a max estimate of 2.05 EUR and a min estimate of 1.75 EUR. Check if this forecast comes true in a year, meanwhile watch NUREXONE BIOLOGIC INC stock price chart and keep track of the current situation with J90 news and stock market news.